
Evolva in sole-source US gov’t talks to advance anti-Zika nootkatone R&D
In Switzerland, Evolva confirmed that the Company is negotiating a sole-source contract with the US Biomedical Advanced Research and Development Authority to advance the development and EPA registration of Evolva’s nootkatone product to help in the fight against the mosquitoes that transmit Zika virus. The news represents the latest expansion of Evolva’s nootkatone work with […]